Biomeme, Inc.

FRANKLIN

Medical molecular diagnostic apparatus for testing naturally-occurring and synthetically-generated nucleic acid, cells, genes and samples thereof; diagnostic kits consisting primarily of probes, buffers and reagents for use in disease testing and also featuring downloadable and recorded computer software for preparing, amplifying, detecting and analyzing target samples of naturally-occurring and synthetically-generated nucleic acid, cells and genes associated with disease testing;

PREDIGEN

Diagnostic testing materials, diagnostic preparations for medical testing purposes, diagnostic preparations, and diagnostic reagents all for the detection and diagnosis of Covid-19; diagnostic testing materials for the detection and diagnosis of viral, bacterial and fungal infections, sepsis, cardiovascular disease, radiation exposure, autoimmune and inflammatory disease and cancer;Medical testing for diagnostic or treatment purposes; medical testing for diagnostic or treatment purposes for diagnosis of Covid-19; medical testing for diagnostic or treatment purposes for diagnosis of viral, bacterial and fungal infections, sepsis, cardiovascular disease, radiation exposure, autoimmune and inflammatory disease and cancer;Biotechnology research; research and development of vaccines and medicines for the treatment of Covid-19; consulting services in the fields of biotechnology, pharmaceutical research and development, genetic science laboratory testing, diagnostics, and pharmacogenetics research; development of new technology for others in the field of biotechnology;

XCEL

Medical diagnostic test kits; medical diagnostic test kits for human and veterinary use; medical diagnostic test kits, namely, Isothermal test kits; molecular medical diagnostic test kits consisting of a test panel for rapidly diagnosing sexually transmitted diseases and infections; molecular medical diagnostic test kits consisting of a respiratory panel for rapidly diagnosing respiratory illness, namely, sars-cov-2 and influenza; molecular testing reagents for medical use; diagnostic test kits comprised of medical respiratory panels and assays for testing of respiratory illness, namely, sars-cov-2 and influenza; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, sars-cov-2 and influenza;Molecular testing reagents for clinical, scientific or research use;